CDSCO approval granted for this game changer Eye Drop

The CDSCO approval of PresVu signifies a significant step forward in Entod's mission to revolutionize eye care solutions in India.

The Health Master

April 17, 2024

377

CDSCO Central Drug Standard Control Organisation — CDSCO

Table of Contents

Last Updated on April 24, 2024 by The Health Master

CDSCO approval

Entod Pharmaceuticals, a leading pharmaceutical company based in Mumbai, has received a significant CDSCO approval from the Central Drugs Standard Control Organisation (CDSCO) to commercialize PresVu, a revolutionary treatment for presbyopia.

This marks a major breakthrough for millions of Indians struggling with this age-related vision condition.

Follow us on WhtasApp Channel

What is Presbyopia?

Presbyopia is a common eye condition that affects people over 40 years old.

It causes a gradual loss of near vision due to the hardening of the eye’s natural lens, making it difficult to focus on close objects like reading materials or smartphones.

This can significantly impact daily activities and quality of life.

Click for more articles on CDSCO

PresVu: A New Dawn for Presbyopia Management

PresVu is the first-of-its-kind eye drop solution in India specifically designed to address presbyopia.

It offers a convenient and potentially life-changing alternative to traditional methods like reading glasses.

Swift Relief: Clinical trials conducted in India and the US have shown that PresVu can improve near vision within minutes of application.
Long-Lasting Effects: The benefits of PresVu can last up to six hours, providing sustained relief throughout the day.
Suitable for Mild to Moderate Presbyopia: PresVu is designed to be particularly effective for individuals aged 40 to 55 with mild to moderate cases of presbyopia.

Click for more Articles on Pharmaceuticals

Click for more Legal Articles on Pharmaceuticals

Empowering Individuals and Advancing Eye Care

Entod Pharmaceuticals is committed to making a positive impact on eye care in India. With PresVu, they aim to:

Reduce Reliance on Reading Glasses: PresVu offers a potential alternative to reading glasses, promoting independence and reducing reliance on corrective eyewear.
Affordable Accessibility: Entod is dedicated to manufacturing PresVu at a competitive price, ensuring affordability and accessibility for all segments of society.
Redefining Eye Care in India: The CDSCO approval of PresVu signifies a significant step forward in Entod’s mission to revolutionize eye care solutions in India.

Looking Ahead

The launch of PresVu is a promising development for millions of Indians coping with presbyopia.

This innovative eye drop solution has the potential to improve near vision, enhance daily activities, and empower individuals to regain visual clarity and independence.

With its focus on affordability and accessibility, PresVu could redefine the way presbyopia is managed in India.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.